BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/19/2022 10:48:04 AM | Browse: 554 | Download: 1280
 |
Received |
|
2022-09-12 16:15 |
|
Peer-Review Started |
|
2022-09-12 16:16 |
|
First Decision by Editorial Office Director |
|
2022-10-19 20:05 |
|
Return for Revision |
|
2022-10-19 20:05 |
|
Revised |
|
2022-11-02 06:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-11-23 03:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-11-23 06:49 |
|
Articles in Press |
|
2022-11-23 06:49 |
|
Edit the Manuscript by Language Editor |
|
2022-11-16 12:15 |
|
Typeset the Manuscript |
|
2022-11-28 02:54 |
|
Publish the Manuscript Online |
|
2022-12-19 10:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Minireviews |
| Article Title |
Liver injury in COVID-19: A minireview
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Wen-Shu Hu, Fang-Ying Jiang, Wen Shu, Rong Zhao, Ji-Min Cao and De-Ping Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Medical Science and Technology Program of Shanxi Province |
2020XM01 |
| Shanxi “1331” Project Quality and Efficiency Improvement Plan |
1331KFC |
| Applied Basic Research Program of Shanxi Province |
202103021224234 |
| National Natural Science foundation of China |
82170523 |
|
| Corresponding Author |
De-Ping Wang, PhD, Lecturer, Department of Physiology, Shanxi Medical University, No. 56 Xinjian Nan Road, Taiyuan 030001, Shanxi Province, China. wangdeping@sxmu.edu.cn |
| Key Words |
Liver; SARS-CoV-2; Angiotensin-converting enzyme 2; Transmembrane serine protease 2; Chronic liver disease |
| Core Tip |
The global pandemic of coronavirus disease 2019 (COVID-19) has imposed a great threat to human health and become a medical and social challenge. Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) mainly affects the respiratory tract, it also frequently damages the liver especially in severe and critical cases. Direct hepatotoxicity of SARS-CoV-2, or indirect hepatic injury caused by immune overactivation and systemic inflammation, drug-induced injury, ischemia/reperfusion and hypoxia/reoxygenation injuries, and worsening of preexisting liver diseases, are potential contributing factors to liver damage in COVID-19. |
| Publish Date |
2022-12-19 10:48 |
| Citation |
Hu WS, Jiang FY, Shu W, Zhao R, Cao JM, Wang DP. Liver injury in COVID-19: A minireview. World J Gastroenterol 2022; 28(47): 6716-6731 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i47/6716.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i47.6716 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
